Uroxatral is a brand name for the drug alfuzosin, an alpha-blocker used in men to treat benign prostatic hyperplasia (BPH).
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Bladder problems | 9 |
|
1 | ||||
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
3 | 100% |
|
|
Expense
|
2 | 67% |
|
|
Doctor's advice
|
2 | 67% |
|
|
Course of treatment ended
|
1 | 33% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.